What stage does Crescent Capital Partners invest at?

Crescent Capital Partners invests at the Series A, Growth, Late Stage stages.

What is Crescent Capital Partners's typical check size?

Crescent Capital Partners typically writes checks of $13.2M – $52.8M.

Where is Crescent Capital Partners located?

Crescent Capital Partners is headquartered in Sydney, AU.

Does Crescent Capital Partners lead rounds?

Yes, Crescent Capital Partners leads investment rounds.

Crescent Capital Partners

Private equity

Sydney · Series A–Late Stage · 24 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into Crescent Capital Partners

788 people in our graph share verified history with the Crescent Capital Partners team — schools, employers, funds. One of them is your warm intro.

Todd Kleinunlockedknows Elizabeth Burgess · together at The Chase Manhattan Bank (overlapped)

×3knows the team · via University of St Andrews

knows the team · via UNSW

knows the team · via Bank of America

knows the team · via Henley Business School

×2knows the team · via L Catterton

✨ Fox Verdict

Investment thesis

Crescent Capital Partners focuses on mid-market and lower mid-market private equity in Australia and New Zealand, using a high-engagement, active investment model to support portfolio businesses with growth and strategic initiatives. Roughly half its investments are in the Australian healthcare sector. Beyond buyouts, the firm has expanded into alternative strategies including an open-ended evergreen private equity fund, diversified Australian corporate loan private credit funds, and a listed equities practice built on fundamental research and active engagement. ESG considerations are embedded across the investment lifecycle to support business resilience and long-term value creation.

Invests inAdvanced Manufacturing Biotech Construction Tech Consumer EdTech Enterprise Software Fintech FoodTech Hardware Healthtech Medical Devices Mobility & Transportation Retail TechSector AgnosticAsia-Pacific Australia Brazil New Zealand Sydney

Source: firm website, verified Sep 15, 2026.

Stage

Series A–Late Stage

Check

$13.2M – $52.8M

Sydney, New South Wales, AU

Leads rounds

Leads

Instruments

Equity · Debt

Founded

2000

AUM

$2B

Team · 24 people

from the firm's website & curated & public directories

Michael Alscher· Founder and Managing Partner· Greater Sydney Areain

Founder and Managing Partner with over 35 years in strategy consulting, investment, business management and public company boards. Previously worked at Bain & Company, LEK Partnership and Chase Manhattan Bank; chairs several portfolio companies.

a•••@crescentcap.com.aureveal

Todd Hixon· Founder and Managing Partnerin 𝕏

Todd Hixon invests broadly in information technology businesses, focusing on companies using deep technology to create commercial value. He co-founded New Atlantic Ventures in 2006, previously served as managing partner of the DFJ New England Fund and as a Senior Vice President at The Boston Consulting Group, and holds a BA in Physics from Princeton and an MBA from Harvard Business School.

t•••@nav.vcreveal

Ondrej Ruzicka· Managing Partner Crescent Growth· Greater Sydney Areain

Managing Partner of Crescent Growth with 16+ years in private equity and investment banking focused on consumer and healthcare across ANZ, Europe and Asia. Formerly Managing Director and Head of ANZ at L Catterton and roles at Goldman Sachs, Nomura and UBS.

Russell Sinclair· Managing Partner Private Credit· Greater Sydney Areain

Managing Partner for Private Credit with 30+ years in banking and finance. Former PwC Partner and senior debt and structured finance leader at Westpac.

Simon Birrell· Managing Partner Listed Equities· London Area, United Kingdomin

Managing Partner for Listed Equities with 20+ years in listed equities, private equity and strategy consulting across the US, Europe and Australia. Former portfolio manager at VGI Partners, Antipodes Partners and Manikay Partners.

Daren McKennay· Partner· Greater Sydney Areain

Partner with 35+ years in the healthcare sector as a CEO and in private equity. Previously co-founder and CEO of Life Healthcare Group, COO of MIA Group and CEO of Healthcare of Australia.

m•••@crescentcap.com.aureveal

Nathanial Thomson· Partner

Partner with 25 years of experience across strategy consulting, private equity and banking. Formerly at McKinsey & Company; chairs several portfolio companies.

t•••@crescentcap.com.aureveal

Neville Buch· Partner

Partner with 40+ years of experience in operating roles and M&A. Former Global Deputy Chairman of Tyco Fire & Security and CEO of Tyco Fire and Security Asia Pacific.

b•••@crescentcap.com.aureveal

Peter Lyon-Mercado· Partner· Greater Bostonin

Partner with 35+ years of experience in financial management and accounting. Previously worked at Saffery in London.

l•••@crescentcap.com.aureveal

Stuart Butterworth· Partner

Partner with 15+ years in strategy consulting and private equity. Previously at A.T. Kearney; chairs EMAPTA and Walski.

b•••@crescentcap.com.aureveal

Elizabeth Burgess· Managing Partner | Crescent Growth· United Statesin

Katie Hastings· Managing Partner - Private Credit· United Kingdomin

Katie Hastings is Managing Partner for Private Credit at Crescent Capital Partners. She has worked in the finance industry at the Managing Director level, with experience spanning credit analysis, leveraged finance, capital markets, private equity, and financial markets.

Giuseppe Valletta· Investment Director· Hong Kong SARin

Investment Director with extensive private equity and investment banking experience focused on consumer and healthcare. Previously a Principal at L Catterton and roles at Goldman Sachs, Pacific Capital and Citi.

Patrick Schmidt· Investment Director

Investment Director with 10+ years across private equity, strategy consulting and M&A. Formerly at McKinsey & Company and King & Wood Mallesons; director of Pinnacle Rehab.

Emily Yang· ESG Director· Xuhui District, Shanghai, Chinain

Managing Director at Cenova Capital who was previously a VP at Duff & Phelps and worked at a risk consulting firm and PwC. Holds degrees from Shanghai University of Finance and Economics and Cass Business School; CFA charterholder with ACCA qualification.

Caitlin Spitzke· CFO/COO Private Credit

CFO/COO of Private Credit with 12+ years in financial management, accounting and operations. Previously at MA Financial Group, Dexus and PwC.

Cressida Mort· Director Investor Relations

Director of Investor Relations with broad experience in relationship management, fundraising and marketing. Previously worked at NAB, ASX and The Armidale School.

Dan Waine· Director New Investments· Greater Sydney Areain

Director of New Investments with 25 years across professional services, banking and private equity. A Chartered Accountant formerly at Ernst & Young.

Eugen Lamotte· CFO Private Equity Funds

CFO of the Private Equity Funds with 12+ years in private equity. Previously worked at Ernst and Young.

Lucy Cooper· Director ESG· Sydney, New South Wales, Australiain

Director of ESG with 10+ years of experience in ESG, sustainable finance and consulting across public and private sectors. Formerly at Bain & Company and the Australian Renewable Energy Agency (ARENA).

Matthew Thomson· Assistant Portfolio Manager· Sydney, New South Wales, Australiain

Assistant Portfolio Manager with 10+ years in listed equities and investment banking. Former portfolio manager at Peregrine Capital in South Africa and Firetrail Investments in Australia.

Peter Scrine· Director Business Development

Director of Business Development with a track record originating investment opportunities and supporting acquisition strategies. Formerly General Manager at WIN Radio and National Partnership Director at Austereo.

David A. Mortimer· Director· Greater Sydney Areain

Timothy D. Martin· Director

Frequently asked questions

What stage does Crescent Capital Partners invest at?: Crescent Capital Partners invests at the Series A, Growth, Late Stage stages.
What is Crescent Capital Partners's typical check size?: Crescent Capital Partners typically writes checks of $13.2M – $52.8M.
What sectors does Crescent Capital Partners focus on?: Crescent Capital Partners focuses on Advanced Manufacturing, Biotech, Construction Tech, Consumer, EdTech, Enterprise Software, Fintech, FoodTech, Hardware, Healthtech, Medical Devices, Mobility & Transportation, Retail Tech, Sector Agnostic.
Where is Crescent Capital Partners located?: Crescent Capital Partners is headquartered in Sydney, AU.
Does Crescent Capital Partners lead rounds?: Yes, Crescent Capital Partners leads investment rounds.

Images

Similar investors

VenturEast

VenturEast is one of India's longest-standing venture capital fund managers, investing since 1997 and managing over $325 million across more than 100 investments in technology, healthcare, and clean environment.

Advent International

Advent International is a global private equity firm that partners with management teams to build market leaders through buyouts, corporate carve-outs, and value creation across selected sectors.

$1.1B

Alibaba Entrepreneurs Fund

The Alibaba Entrepreneurs Fund is a not-for-profit initiative of Alibaba Group that provides investment capital and strategic guidance to entrepreneurs and young people, focusing on Hong Kong and Taiwan-nexus startups.

$1.2M – $150M

MPG Fund

MPG Fund is an early-stage venture investor backing technology startups.

Norwest Venture Partners

Norwest Venture Partners is an investment firm whose growth equity team backs private, profitable, fast-growing companies, providing capital and hands-on support through its 'invited guest' approach.

$10M – $30M